| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | A. Wirth | |
| P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
| Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
| Effect of sibutramine on weight maintenance after weight loss: a randomised trial | Q33128832 | ||
| Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial | Q33425402 | ||
| Economic costs of obesity and inactivity | Q33792165 | ||
| Long-term weight-loss maintenance: a meta-analysis of US studies | Q34099650 | ||
| Long-term weight loss with sibutramine: a randomized controlled trial | Q43740082 | ||
| Sibutramine in clinical practice - a PMS-study with positive effects on blood pressure and metabolic parameters | Q43926868 | ||
| Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial | Q44007390 | ||
| Effect of orlistat-induced weight loss on blood pressure and heart rate in obese patients with hypertension | Q44113844 | ||
| Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction | Q44135204 | ||
| Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine | Q47265863 | ||
| Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group | Q47284487 | ||
| Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range | Q47359474 | ||
| Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study | Q47693449 | ||
| A descriptive study of weight loss maintenance: 6 and 15 year follow-up of initially overweight adults | Q57257489 | ||
| Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers | Q72066041 | ||
| Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients | Q73694844 | ||
| Obesity in Switzerland: a critical assessment of prevalence in children and adults | Q74601469 | ||
| Sibutramine: a novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from d-amphetamine and d-fenfluramine | Q77363263 | ||
| Sibutramine and fat distribution: is there a role for pharmacotherapy in abdominal/visceral fat reduction? | Q77363270 | ||
| Obesity | Q77665702 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | German | Q188 |
| P921 | main subject | internal medicine | Q11180 |
| P304 | page(s) | 359-62, 363-6 | |
| P577 | publication date | 2003-03-01 | |
| P1433 | published in | Die Innere Medizin | Q1194574 |
| P1476 | title | Weight loss via drug therapy | |
| P478 | volume | 44 |
Search more.